ASX:MIN.AX News 17 January 2026

Mineral Resources (ASX:MIN) share price drops 6% despite lithium guidance upgrade

Mineral Resources Ltd shares fell 6.3% to A$57.15 Friday after reporting a 29% jump in spodumene prices and raising lithium output forecasts. The S&P/ASX 200 dropped 0.65%, with lithium stocks hit hard as prices slid 11% in Asia. Net debt fell to about A$4.9 billion, and cash liquidity topped A$1.4 billion. Broker ratings diverged, with Macquarie upgrading to outperform and Jarden warning on costs.

31 January 2026

ASX:MIN.AX·Lithium·Mining Industry·Stock Market

Mineral Resources share price tumbles 6% as MinRes lifts lithium guidance but flags write-down risk

Shares of Mineral Resources fell 6.3% to A$57.15 after its quarterly update, despite higher FY26 lithium guidance and a drop in net debt to A$4.9 billion. The company reported a 29% rise in spodumene prices and confirmed a US$765 million POSCO deal. Investors await half-year results on February 20 and updates on the Bald Hill restart.

30 January 2026

ASX:MIN.AX·Stock Market

Mineral Resources share price slid Friday — what to watch before ASX trade resumes

Mineral Resources shares fell 2.4% to A$59.78 Friday, closing a volatile week as iron ore and lithium prices slipped. Iron ore futures in Dalian ended at 812 yuan a tonne, down 4 yuan. Investors await Mineral Resources’ December-quarter results on Jan. 29. The company reported progress on safety upgrades at its Onslow Iron supply chain.

17 January 2026

ASX News·ASX:MIN.AX·Stock Market

IBM stock price jumps 3% into weekend as Confluent vote and dividend date near

7 February 2026

IBM shares closed up 3.1% at $298.93 Friday, outperforming some tech peers as U.S. stocks rebounded. The move followed IBM’s announcement of a Missile Defense Agency contract and comes ahead of a Feb. 12 Confluent shareholder vote on IBM’s $11 billion acquisition proposal.

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

7 February 2026

Philip Morris International closed at $182.81, up 0.45%, after raising its 2026 profit outlook on stronger nicotine pouch sales. Fourth-quarter adjusted EPS rose to $1.70, with net revenue up 6.8% to $10.36 billion. CEO Jacek Olczak said updated Zyn products are pending regulatory approval. The next dividend declaration is set for March 5, 2026.

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

ASX:MIN.AX News 17 January 2026 - 31 January 2026

Mineral Resources (ASX:MIN) share price drops 6% despite lithium guidance upgrade

Mineral Resources share price tumbles 6% as MinRes lifts lithium guidance but flags write-down risk

Mineral Resources share price slid Friday — what to watch before ASX trade resumes

Stock Market Today

IBM stock price jumps 3% into weekend as Confluent vote and dividend date near

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

AstraZeneca stock price: What could move AZN next week as earnings loom